Pfizer

19 Archived Projects

Title Investigator Start
End
HIV Clinical Scholars Fellowship Lin
A Randomized, Double Blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy &Safety of Atorvastatin in Patients w/ Clinically Isolated Syndrome & High Risk for Conversion to M.S. Bluestone
Twelve-Week Study Evaluating the Safety and Efficacy of Varenicline Tartrate ( CP-526,555) in Comparison to Zyban for Smoking Cessation Reus
International Fellowship Program in Drug Development
A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial of a Novel CCR5 Antagonist, UK427,857, for the Treatment of Antiretroviral-Experienced HIV-1-Infected Subjects Luetkemeyer
The Use of Nelfinavir During Acute or Early HIV Infection - Safety, Tolerability, Durablilty and Resistance Hare
Phase IV Open-Label, Non-comparative Trial of IV Anidulafungin followed by Oral Azole Therapy for the Treatment of Candidemia and Invasive Candidiasis
Pfizer A4001027: Observational Phase Extension Luetkemeyer
QB3-UCSF Pfizer Collaboration Kelly
A8851009: A Prospective, Randomized Trial Comparing the Efficacy of Anidulafungin and Voriconazole in Combination to that of Voriconazole Alone When Used For Primary Therapy of Proven or Probable Invasive Aspergillosis
Pfizer International Growth Study (KIGS) - Protocol TRN 87-052-45 (CCID A6281276) Rosenthal
Rifabutin Based Therapy for Eradication of Staph Carriage in HIV-Infected Individuals with Prior Skin Structure Infections Chambers
Mycotic Ulcer Treatment Trial (MUTT) Acharya
Efficacy and Safety of Eraxis/Ecalta (Anidulafungin) Compared to Cancidas (Caspofungin) in Patients with Candida Deep Tissue Infection: A Phase 4 Study
ViiV Healthcare A4001098 Luetkemeyer
Effects of Maraviroc on HIV-related Kaposi Sarcoma Maurer
Accelerating and Intensifying Tuberculosis Case Finding in Uganda Davis
UCSF Cutaneous Immunology Core: OSM Project Rosenblum
Exploring the Role of CDK4 and CDK6 in Melanoma Maintenance